Bovipast RSP

Product Information for Public -

While management factors are important in respiratory disease control, vaccination plays a critical role.  Bovipast RSP helps protect against the most harmful virus, RSV and one of the most common, PI3.  It is also the only combined vaccine that can reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung by Mannheimia (Pasteurella) haemolytica.  Bovipast RSP can be used in calves from as young as two weeks old and immunity can be achieved by 8 weeks of age.  The primary vaccination course consists of two 5ml doses given four weeks apart.

 

Legal Category:  POM-V

Bovilis Bovipast RSP contains inactivated bovine RSV (strain EV908), Para-influenza 3 virus (strain SF-4 Reisinger) and inactivated Mannheimia haemolytica (serotype A1).  For uses, dosage, contra-indications and warnings, see data sheet. Bovilis Bovipast RSP may only be prescribed by your veterinary surgeon from whom advice should be sought.  Further information is available on request.